---
title: "Life360, Inc. Stock 12‑Month Price Target Raised to $62.43, Implies 12% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292913076.md"
description: "Analysts have raised the average 12-month price target for Life360, Inc. stock from $61.57 to $62.43, implying a 12% upside based on the July 15 closing price. The consensus rating remains 'Buy' among nine covering analysts, with seven buys and two holds."
datetime: "2026-07-16T13:20:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292913076.md)
  - [en](https://longbridge.com/en/news/292913076.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292913076.md)
generator: "portal-rs"
---

# Life360, Inc. Stock 12‑Month Price Target Raised to $62.43, Implies 12% Upside

-   According to estimates from 7 analysts, Life360, Inc. stock's average price target has risen from $61.57 to $62.43, with forecasts ranging from $42 to $72 per share
-   Based on the Jul. 15 closing price, the updated target implies approximately 12% potential upside
-   Consensus rating remains at “Buy” across 9 covering analysts, with 7 Buys, 2 Holds and 0 Sells

Explore more price target data and ratings for Life360, Inc. on the , and track all previous and future analyst recommendations for Life360, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [LIF.US](https://longbridge.com/en/quote/LIF.US.md)
- [360.AU](https://longbridge.com/en/quote/360.AU.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Life360 Insider Makes Major Move With High-Value Stock Sale](https://longbridge.com/en/news/297268554.md)
- [ONEnergy Inc. Unaware Of Material Change](https://longbridge.com/en/news/299080052.md)
- [Janus Living, Inc. declares $0.0475 dividend](https://longbridge.com/en/news/299024882.md)
- [TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Given Consensus Recommendation of "Hold" by Analysts](https://longbridge.com/en/news/298456154.md)
- [Winthrop Wealth Named to the 2026 Inc. 5000](https://longbridge.com/en/news/298932734.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**